Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: An in vitro study;Allogene transplantations-möglichkeiten humaner mesenchymaler stammzellen: Eine in-vitro-studiezur knochenregeneration

Orthopade

Volumn 33, Issue 12, 2004, Pages 1346-1353

  Niemeyer, P ^a   Seckinger, A ^b   Simank, H G ^b   Kasten, P ^b   Sudkamp N ^a   Krause, U ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Bone regeneration; HLA DR; Mesenchymal stem cell; Mixed lymphocyte reaction; Tissue engineering

Indexed keywords

ASCORBIC ACID; DEXAMETHASONE; GLYCEROL 2 PHOSPHATE; HLA ANTIGEN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BIOLOGICAL MONITORING; CARTILAGE; CELL DIFFERENTIATION; CELL ISOLATION; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE; MESENCHYMAL STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TISSUE ENGINEERING; ALLOTRANSPLANTATION; BONE REGENERATION; CYTOLOGY; FLUORESCENCE MICROSCOPY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METHODOLOGY; OSTEOBLAST; PHYSIOLOGY;

BONE REGENERATION; CELL DIFFERENTIATION; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELLS; MICROSCOPY, FLUORESCENCE; OSTEOBLASTS; TISSUE ENGINEERING; TRANSPLANTATION, HOMOLOGOUS;

EID: 13644262261     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-004-0731-3     Document Type: Article

References (25)

1. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M (1980) Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop 151: 294-307
2. Awad HA, Butler DL, Harris MT et al. (2000) In vitro characterization of mesenchymal stem cell-seeded collagen scaffolds for tendon repair: effects of initial seeding density on contraction kinetics. J Biomed Mater Res 51: 233-240
3. Bach FH (1973) The major histocompatibility complex in transplantation immunology. Transplant Proc 5: 23-29
4. Cancedda R, De Luca M (1993) Tissue engineering for clinical application. Year Immunol 7: 193-198
5. Cancedda R, Dozin B, Giannoni P, Quarto R (2003) Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 22: 81-91
6. Chen JL, Guo ZK, Xu C, Li YH, Hou CM, Mao N, Chen H (2002) Mesenchymal stem cells suppress allogeneic T cell responses by secretion of TGF-beta1. Zhongguo Shi Yan Xue Ye Xue Za Zhi 10: 285-288
7. Dean RM, Bishop MR (2003) Graft-versus-host disease: emerging concepts in prevention and therapy. Curr Hematol Rep 2: 287-294
8. DiNicola M, Carlo-Stella C, Magni M et al. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non-specific mitogenic stimuli. Blood 99: 3838-3843
9. Kasten P, Luginbuhl R, van Griensven M, Barkhausen T, Krettek C, Bohner M, Bosch U (2003) Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix. Biomaterials 24: 2593-2603
10. Kornacker M, Verneris MR, Kornacker B, Scheffold C, Negrin RS (2001) Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells. Immunol Lett 76: 169-173
11. Kovacic JC, Graham RM (2004) Stem-cell therapy for myocardial diseases. Lancet 363: 1735-1736
12. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57: 11-20
13. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991-1045
14. Niemeyer P, Krause U, Punzel M, Fellenberg J, Simank HG (2003) Mesenchymale Stammzellen zum Tissue Engineering von Knochen: 3-D-Kultivierung und Osteogene Differenzierung auf mineralisiertem Kollagen. Z Orthop 141: 712-717
15. Ohgushi H, Goldberg VM, Caplan AI (1989) Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop Scand 60: 334-339
16. Pittenger MF, Mackay AM, Beck SC et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147
17. Rasmusson I, Ringden O, Sundberg B, Le Blanc K (2003) Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76: 1208-1213
18. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM (2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615-2625
19. Rothstein DM, Sayegh MH (2003) T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 196: 85-108
20. Service RF (2000) Tissue engineers build new bone. Science 289: 1498-1500
21. Shang Q, Wang Z, Liu W, Shi Y, Cui L, Cao Y (2001) Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells. J Craniofac Surg 12: 586-593
22. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD (2004) Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363: 783-784
23. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M (2002) Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 10: 199-206
24. Wakitani S, Yamamoto T (2002) Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect. Microsc Res Tech 58: 14-18
25. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ (1998) Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16: 406-413